Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Gene Identified That May Increase Risk for Preterm Birth

By LabMedica International staff writers
Posted on 26 Apr 2011
Evolutionary changes that make people uniquely human may have driven human birth timing earlier and can be used to identify genes associated with preterm birth.

Investigators from Vanderbilt University (Nashville, TN, USA), Washington University at St. More...
Louis (MO, USA) , and the University of Helsinki (Finland) reported that variations in a gene with accelerated evolution in humans, the follicle-stimulating hormone receptor (FSHR), may increase a woman's risk for delivering her infant prematurely. The study's findings in the April 14, 2011, open-access journal PLoS Genetics point to a novel biologic pathway that may influence birth timing.

More than half a million babies per year in the US alone--one in eight--are born prematurely (before 37 weeks of gestation). Premature babies face an increased risk of death and serious short-term and long-term medical complications, yet there are no adequate therapies to prevent preterm birth.

"Part of the problem is that we don't understand the fundamental biology of human pregnancy and birth timing,” said Louis Muglia, MD, PhD, professor and vice chair for Research Affairs in the Vanderbilt department of pediatrics. "We don't know if preterm birth in humans is the normal process gone awry, or if it's an entirely distinct process.” Attempts to use animal models to understand human pregnancy have been of limited success, Dr. Muglia said, "The signals that control pregnancy and birth timing in animal models aren't able to be extended to humans; human pregnancy differs from pregnancy in other animal species.”

Dr. Muglia and his colleagues theorized that humans' large heads and narrow pelvises have put pressure on human pregnancy "to adapt and shift the time of birth to the earliest time compatible with optimal survival for both the mom and the fetus.”

To examine whether this notion of evolutionary pressure on birth timing had merit, the researchers compared the length of gestation in humans and nonhuman primates. They demonstrated in the current study that gestation length has decreased in the evolutionary lineage leading to modern humans.

The scientists also compared body and brain sizes at birth in humans and nonhuman primates, in a process called allometric scaling, and demonstrated that human gestation is shorter than would be predicted based on this comparison. "We think there is good evidence that human gestation has been pushed to shorter times, which means there should be a ‘signature' in the human genome--genes with accelerated evolution to accommodate this process,” Dr. Muglia remarked.

Justin Fay, PhD, associate professor of genetics at Washington University and coleader of the study, developed comparative genomic techniques to identify "human accelerated genes”--genes that are most altered in humans compared to six other animals. The researchers identified a set of 450 human accelerated genes and narrowed the list to 150 genes that were plausible candidates for having a role in human pregnancy.

They examined variations in these 150 genes in a cohort of Finnish mothers and found that specific variations in the FSHR gene were more frequent in mothers who had experienced preterm birth. The same variations may also be linked to preterm birth in African-Americans, additional study suggested. The FSHR gene has not previously been implicated in the timing for birth or preterm birth risk.

Studies in larger cohorts could lead to additional accelerated genes with roles in birth timing and provide new targets for therapeutic or preventive measures, Dr. Muglia said. "Ideally we'd like to predict which women are at greatest risk for having preterm birth and be able to prevent it. That would really have an impact on infant mortality and the long-term complications of being born prematurely.”

Related Links:

Vanderbilt University
Washington University in St. Louis
University of Helsinki




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.